The Psychedelic Handbook

Learn everything you need to know about psychedelics with this ultimate guide packed with information on popular psychedelic drugs like psilocybin, ketamine, MDMA, DMT and LSD—plus practical tips for microdosing and how to safely "trip"—from bestselling author Dr. Rick Strassman. Entering the world of psychedelic drugs can be challenging, and many aren’t sure where to start. As research continues to expand and legalization looms on the horizon for psychedelics like psilocybin, you may need a guide to navigate what psychedelics are, how they work, and their potential benefits and risks. The Psychedelic Handbook is a complete manual that is accessible to anyone with an interest in these “mind-manifesting” substances. Packed with information on psilocybin, LSD, DMT/ayahuasca, mescaline/peyote, ketamine, MDMA, ibogaine, 5-methoxy-DMT (“the toad”), and Salvia divinorum/salvinorin A, this book is your ultimate reference for understanding the science and history of psychedelics; discovering their potential to treat depression, PTSD, substance abuse, and other disorders, as well as to increase wellness, creativity, and meditation; learning how to safely trip and explaining what we know about microdosing; and recognizing and caring for negative reactions to psychedelics. Clinical research psychiatrist, founding figure of the American psychedelic research renaissance, and best-selling author of DMT: The Spirit Molecule, Dr. Rick Strassman shares his experience and perspectives as neither advocate nor foe of psychedelics in order to help readers understand the effects of these remarkable drugs.

Psychedelics for spiritual, therapeutic, and problem-solving use • Presents practices for safe and successful psychedelic voyages, including the benefits of having a guide and how to be a guide • Reviews the value of psychedelics for healing and self-discovery as well as how LSD has facilitated scientific and technical problem-solving • Reveals how microdosing (ultr-low doeses) improve cognitive functioning, emotional balance, and physical stamina • This year 600,000 people in the U.S. alone will try LSD for the the first time, joining the 23 million who have already experimented with this substance Called “America’s wisest and most respected authority on psychedelics and their use,” James Fadiman has been involved with psychedelic research since the 1960s. In this guide to the immediate and long-term effects of psychedelic use for spiritual (high dose), therapeutic (moderate dose), and problem-solving (low dose and microdose) purposes, Fadiman outlines best practices for safe, sacred entheogenic voyages learned through his more than 40 years of experience--from the benefits of having a sensitive guide during a session (and how to be one) to the importance of the setting and pre-session intention. Fadiman reviews the newest as well as the neglected research into the psychotherapeutic value of visionary drug use for increased personal awareness and a host of serious medical conditions, including his recent study of the reasons for and results of psychedelic use among hundreds of students and professionals. He reveals new uses for LSD and other psychedelics, including microdosing, extremely low doses, for improved cognitive functioning and emotional balance. Cautioning that psychedelics are not for everyone, he dispels the myths and misperceptions about psychedelics circulating in textbooks and clinics as well as on the internet. Exploring the life-changing experiences of Ram Dass, Timothy Leary, Aldous Huxley, and Huston Smith as well as Francis Crick and Steve Jobs, Fadiman shows how psychedelics, used wisely, can lead not only to healing but also to scientific breakthroughs and spiritual epiphanies.

This handbook reviews promising applications of psychedelics in treatment of such challenging psychiatric problems as posttraumatic stress disorder, major depression, substance use disorders, and end-of-life anxiety. Experts from multiple disciplines synthesize current knowledge on psilocybin, MDMA, ketamine, and other medical hallucinogens. The volume comprehensively examines these substances' neurobiological mechanisms, clinical effects, therapeutic potential, risks, and anthropological and historical contexts. Coverage ranges from basic science to practical clinical considerations, including patient screening and selection, dosages and routes of administration, how psychedelic-assisted sessions are structured and conducted, and management of adverse reactions.

"Microdosing, or taking between 1/10th and 1/20th of the normal dose of a psychedelic drug is the latest way to improve performance, stave off chronic pain, and alleviate a variety of other ailments like anxiety and depression. Unlike a psychedelic trip, microdosing does not alter your mental status or interfere with day-to-day life. Part handbook and part workbook, The Microdosing Guidebook is your ultimate reference for safely using psychedelic medicine." --

Please note: This is a companion version & not the original book. Sample Book Insights: #1 Psychedelics are drugs that reliably produce a unique state of mind in which you see visions and hear voices. They reliably produce a state of mind in which you feel ecstasy and terror, or nothing at all. The history of human beings using these drugs stretches back thousands of years, but their use reached its height in the 1960s and 1970s. During those two decades, hundreds of thousands of people used psychedelics at least once. Opium, the first ever drug to be used for its mind-altering qualities rather than its painkilling properties, was first used by Chinese emperor Shen Nung more than five thousand years ago. It was then cultivated by Indian physicians and used to treat depression and headaches. It would eventually become one of the most popular drugs in the history of human civilization. During the nineteenth century, it was often smoked in water pipes, and it was often combined with cocaine and alcohol, creating a powerful cocktail known as jimsonweed tea. The first American to use LSD was most likely a self-experimenter named Albert Hofmann. He accidentally ingested himself one hundred times the dose he intended to use on his friends. His life was never the same again. #2 Psychedelics are drugs that reliably produce a unique state of mind in which you see visions and hear voices. They reliably produce a state of mind in which you feel ecstasy and terror, or nothing at all. #3 LSD, the first ever drug used for its mind-altering qualities rather than its painkilling properties, was first used by Chinese emperor Shen Nung more than five thousand years ago. It was then cultivated by Indian physicians and used to treat depression and headaches. It would eventually become one of the most popular drugs in the history of human civilization. #4 The history of humankind using psychedelics stretches back thousands of years. During the 1960s and 1970s, hundreds of thousands of people used psychedelics at least once.

An investigation into experiences of other realms of existence and contact with otherworldly beings • Examines how contact with alien life-forms can be obtained through the “inner space” dimensions of our minds • Presents evidence that other worlds experienced through consciousness-altering technologies are often as real as those perceived with our five senses • Correlates science fiction’s imaginal realms with psychedelic research For thousands of years, voyagers of inner space--spiritual seekers, shamans, and psychoactive drug users--have returned from their inner imaginal travels reporting encounters with alien intelligences. Inner Paths to Outer Space presents an innovative examination of how we can reach these other dimensions of existence and contact otherworldly beings. Based on their more than 60 combined years of research into the function of the brain, the authors reveal how psychoactive substances such as DMT allow the brain to bypass our five basic senses to unlock a multidimensional realm of existence where otherworldly communication occurs. They contend that our centuries-old search for alien life-forms has been misdirected and that the alien worlds reflected in visionary science fiction actually mirror the inner space world of our minds. The authors show that these “alien” worlds encountered through altered states of human awareness, either through the use of psychedelics or other methods, possess a sense of reality as great as, or greater than, those of the ordinary awareness perceived by our five senses.

Explores the potential of psychedelics as medicine and the intersections of politics, science, and psychedelics • Explores the tumultuous history of psychedelic research, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental illness • Offers non-technical summaries of the most recent, double-blind, placebo-controlled studies with MDMA, psilocybin, LSD, and ayahuasca • Includes the work of Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker. Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob’s research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate’s attempt to transport this plant medicine to a clinical setting with the help of Canada’s Department of National Health. Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.

Psychedelic Psychotherapy contains valuable insiders' information for those using psychedelics for their own healing, and for practitioners who facilitate their sessions. Its focus is the nitty-gritty of healing trauma using MDMA, LSD, and psilocybin.